- Report
- January 2022
- 200 Pages
Global
From €6640EUR$7,500USD£5,751GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €443EUR$500USD£383GBP
Rapamune is a drug used to treat immune disorders, such as kidney transplant rejection and psoriasis. It is an immunosuppressant, meaning it works by suppressing the body's immune system to prevent it from attacking transplanted organs or other parts of the body. Rapamune is typically used in combination with other drugs to reduce the risk of organ rejection. It is also used to treat certain autoimmune diseases, such as lupus and rheumatoid arthritis.
Rapamune is available in both oral and intravenous forms. It is typically prescribed by a doctor and is available in generic and brand-name versions. Common side effects of Rapamune include nausea, vomiting, diarrhea, and headache.
The Rapamune market is highly competitive, with several companies offering similar products. Some of the major players in the market include Pfizer, Novartis, Merck, and Bristol-Myers Squibb. Other companies in the market include Astellas Pharma, Sanofi, and GlaxoSmithKline. Show Less Read more